Table 5.

Correlations between TAM subset numbers and clinicopathological characteristics in TNBC

Clinicopathological features		CD68	CD163			CSF-1R			CD206
		Total	M2-like	M1-like	Ratio	M2-like	M1-like	Ratio	M2-like	M1-like	Ratio
Agea	R	0.097	0.001	0.052	0.005	0.121	− 0.168	0.136	0.065	0.040	− 0.011
	P	0.374	0.989	0.633	0.967	0.267	0.123	0.212	0.555	0.712	0.919
Menopausal statusb	P	0.734	0.075	0.040	0.015	0.730	0.249	0.505	0.622	0.821	0.856
Premenopausal	Median	35.5	175.83	1	131.33	49.17	1	19.17	48.5	1	18.3
Perimenopausal	Median	15.33	44	1	39.67	62.33	1	55	19.33	5.33	1.88
Postmenopausal	Median	37.33	142	1	142	82.67	1	82.67	61	1	20.67
Tumour gradeb	P	0.055	0.034	0.181	0.037	0. 971	0.547	0. 859	0.446	0.270	0.929
Grade 1	Median	2.33	16.5	1	16.50	203.00	1	203.00	35.00	1	35.00
Grade 2	Median	14.67	61	1	46.33	63.00	1	36.00	36.67	1	25.00
Grade 3	Median	39.92	146.83	1	128.50	79.5	1	53.17	50.00	1	16.26
Tumour sizea	r	− 0.008	1460.040	0.078	0.078	0.127	− 0.113	0.148	0.057	− 0.002	0.095
	P	0.946	0.719	0.479	0.480	0.248	0.305	0.262	0.605	0.986	0.388
Lymph node statusb	P	0.877	0.779	0.349	0.493	0.727	0.625	0.810	0.412	0.931	0.666
Positive	Median	36	142	1	115	51.33	1	35.67	40.67	1	20.67
Negative	Median	35	112.67	1	89	97.33	1	62.33	48.33	1	17
Lymphovascular invasionb	P	0.141	0.028	0.208	0.023	0.767	0.021	0.109	0.981	0.083	0.136
Positive	Median	92.67	184	1	182	43.67	18.67	1.27	45.33	28.33	0.98
Negative	Median	24.33	94.17	1	81.67	75.83	1	58.67	45.5	1	20.67

*P ≤ 0.005

^aSpearman’s rho

^bKruskal–Wallis test

^cMann–Whitney U test

r—correlation coefficient, P—P value, Median—median TAM subset number